Fat as an endocrine organ: Influence of exercise

Journal of Applied Physiology

Volumn 99, Issue 2, 2005, Pages 757-764

  Berggren, Jason R ^a   Hulver, Matthew W ^b   Houmard, Joseph A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Adipocytokines; Insulin sensitivity; Metabolism

Indexed keywords

ADIPOCYTOKINE;

DIABETES MELLITUS; ENERGY BALANCE; EXERCISE; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SATIETY;

ADIPOSE TISSUE; ANIMALS; CYTOKINES; DIABETES MELLITUS; ENDOCRINE GLANDS; EXERCISE; EXERCISE THERAPY; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; MUSCLE, SKELETAL;

EID: 23044506721     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00134.2005     Document Type: Review

References (120)

1. Abbasi F, Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM, and Reaven PD. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53: 585-590, 2004.
2. Ahmad AM, Guzder R, Wallace AM, Thomas J, Fraser WD, and Vora JP. Circadian and ultradian rhythm and leptin pulsatility in adult GH deficiency: effects of GH replacement. J Clin Endocrinol Metab 86: 3499-3506, 2001.
3. Ahren B. Diurnal variation in circulating leptin is dependent on gender, food intake and circulating insulin in mice. Acta Physiol Scand 169: 325-331, 2000.
4. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83, 1999.
5. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, and Saruta T. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 11: 997-1001, 2003.
6. Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN, Moizo L, Lehy T, Guerre-Millo M, Le Marchand-Brustel Y, and Lewin MJ. The stomach is a source of leptin. Nature 394: 790-793, 1998.
7. Bruce CR and Dyck DJ. Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-α. Am J Physiol Endocrinol Metab 287: E616-E621, 2004.
8. Casanueva FF and Dieguez C. Neuroendocrine regulation and actions of leptin. Front Neuroendocrinol 20: 317-363, 1999.
9. Cha MC, Chou CJ, and Boozer CN. High-fat diet feeding reduces the diurnal variation of plasma leptin concentration in rats. Metabolism 49: 503-507, 2000.
10. Cheung AT, Ree D, Kolls JK, Fuselier J, Coy DH, and Bryer-Ash M. An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. Endocrinology 139: 4928-4935, 1998.
11. Christensen JO, Svendsen OL, Hassager C, and Christiansen C. Leptin in overweight postmenopausal women: no relationship with metabolic syndrome X or effect of exercise in addition to diet. Int J Obes Relat Metab Disord 22: 195-199, 1998.
12. Ciaraldi TP, Carter L, Mudaliar S, Kern PA, and Henry RR. Effects of tumor necrosis factor-alpha on glucose metabolism in cultured human muscle cells from nondiabetic and Type 2 diabetic subjects. Endocrinology 139: 4793-4800, 1998.
13. Cinti S, Frederich RC, Zingaretti MC, De Matteis R, Flier JS, and Lowell BB. Immunohistochemical localization of leptin and uncoupling protein in white and brown adipose tissue. Endocrinology 138: 797-804, 1997.
14. Comuzzie AG, Funahashi T, Sonnenberg G, Martin LJ, Jacob HJ, Black AE, Maas D, Takahashi M, Kihara S, Tanaka S, Matsuzawa Y, Blangero J, Cohen D, and Kissebah A. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86: 4321-4325, 2001.
15. Cooney GJ, Thompson AL, Furler SM, Ye J, and Kraegen EW. Muscle long-chain acyl CoA esters and insulin resistance. Ann NY Acad Sci 967: 196-207, 2002.
16. Dallongeville J, Hecquet B, Lebel P, Edme JL, Le Fur C, Fruchart JC, Auwerx J, and Romon M. Short term response of circulating leptin to feeding and fasting in man: influence of circadian cycle. Int J Obes Relat Metab Disord 22: 728-733, 1998.
17. Dengel DR, Pratley RE, Hagberg JM, Rogus EM, and Goldberg AP. Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J Appl Physiol 81: 318-325, 1996.
18. Dietze D, Koenen M, Rohrig K, Horikoshi H, Hauner H, and Eckel J. Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 51: 2369-2376, 2002.
19. Drenth JP, Van Uum SH, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, and Van der Meer JW. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-α and IL-1β production. J Appl Physiol 79: 1497-1503, 1995.
20. Duclos M, Corcuff JB, Ruffie A, Roger P, and Manier G. Rapid leptin decrease in immediate post-exercise recovery. Clin Endocrinol (Oxf) 50: 337-342, 1999.
21. Elias AN, Pandian MR, Wang L, Suarez E, James N, and Wilson AF. Leptin and IGF-I levels in unconditioned male volunteers after short-term exercise. Psychoneuroendocrinology 25: 453-461, 2000.
22. Esler M, Vaz M, Collier G, Nestel P, Jennings G, Kaye D, Seals D, and Lambert G. Leptin in human plasma is derived in part from the brain, and cleared by the kidneys. Lancet 351: 879, 1998.
23. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, and Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289: 1799-1804, 2003.
24. Essig DA, Alderson NL, Ferguson MA, Bartoli WP, and Durstine JL. Delayed effects of exercise on the plasma leptin concentration. Metabolism 49: 395-399, 2000.
25. Fain JN, Bahouth SW, and Madan AK. TNFalpha release by the nonfat cells of human adipose tissue. Int J Obes Relat Metab Disord 28: 616-622, 2004.
26. Fain JN, Cheema PS, Bahouth SW, and Lloyd Hiler M. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 300: 674-678, 2003.
27. Fain JN, Madan AK, Hiler ML, Cheema P, and Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145: 2273-2282, 2004.
28. Febbraio MA, Steensberg A, Starkie RL, McConell GK, and Kingwell BA. Skeletal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with Type 2 diabetes at rest and during exercise. Metabolism 52: 939-944, 2003.
29. Ferguson MA, White LJ, McCoy S, Kim HW, Petty T, and Wilsey J. Plasma adiponectin response to acute exercise in healthy subjects. Eur J Appl Physiol 91: 324-329, 2004.
30. Fisher JS, Van Pelt RE, Zinder O, Landt M, and Kohrt WM. Acute exercise effect on postabsorptive serum leptin. J Appl Physiol 91: 680-686, 2001.
31. Friedman JM and Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
32. Gallagher D, Kuznia P, Heshka S, Albu J, Heymsfield SB, Goodpaster B, Visser M, and Harris TB. Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr 81: 903-910, 2005.
33. Gong DW, Bi S, Pratley RE, and Weintraub BD. Genomic structure and promoter analysis of the human obese gene. J Biol Chem 271: 3971-3974, 1996.
34. Havel PJ. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc 59: 359-371, 2000.
35. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53, Suppl 1: S143-S151, 2004.
36. Hayase H, Nomura S, Abe T, and Izawa T. Relation between fat distributions and several plasma adipocytokines after exercise training in premenopausal and postmenopausal women. J Physiol Anthropol Appl Human Sci 21: 105-113, 2002.
37. Heilbronn LK, Rood J, Janderova L, Albu JB, Kelley DE, Ravussin E, and Smith SR. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 89: 1844-1848, 2004.
38. Herrmann TS, Bean ML, Black TM, Wang P, and Coleman RA. High glycemic index carbohydrate diet alters the diurnal rhythm of leptin but not insulin concentrations. Exp Biol Med (Maywood) 226: 1037-1044, 2001.
39. Hickey MS, Considine RV, Israel RG, Mahar TL, McCammon MR, Tyndall GL, Houmard JA, and Caro JF. Leptin is related to body fat content in male distance runners. Am J Physiol Endocrinol Metab 271: E938-E940, 1996.
40. Hickey MS, Houmard JA, Considine RV, Tyndall GL, Midgette JB, Gavigan KE, Weidner ML, McCammon MR, Israel RG, and Caro JF. Gender-dependent effects of exercise training on serum leptin levels in humans. Am J Physiol Endocrinol Metab 272: E562-E566, 1997.
41. Hilton LK and Loucks AB. Low energy availability, not exercise stress, suppresses the diurnal rhythm of leptin in healthy young women. Am J Physiol Endocrinol Metab 278: E43-E49, 2000.
42. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, and Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409-2415, 1995.
43. Hotamisligil GS, Budavari A, Murray D, and Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 94: 1543-1549, 1994.
44. Hotamisligil GS, Shargill NS, and Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91, 1993.
45. Houmard JA, Cox JH, MacLean PS, and Barakat HA. Effect of short-term exercise training on leptin and insulin action. Metabolism 49: 858-861, 2000.
46. Houmard JA, Tanner CJ, Yu C, Cunningham PG, Pories WJ, MacDonald KG, and Shulman GI. Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes 51: 2959-2963, 2002.
47. Hu E, Liang P, and Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703, 1996.
48. Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, Pories WJ, MacDonald KG, Cline GW, Shulman GI, Dohm GL, and Houmard JA. Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284: E741-E747, 2003.
49. Hulver MW, Saleh O, MacDonald KG, Pories WJ, and Barakat HA. Ethnic differences in adiponectin levels. Metabolism 53: 1-3, 2004.
50. Hulver MW, Zheng D, Tanner CJ, Houmard JA, Kraus WE, Slentz CA, Sinha MK, Pories WJ, MacDonald KG, and Dohm GL. Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283: E861-E865, 2002.
51. Ishii T, Yamakita T, Yamagami K, Yamamoto T, Miyamoto M, Kawasaki K, Hosoi M, Yoshioka K, Sato T, Tanaka S, and Fujii S. Effect of exercise training on serum leptin levels in Type 2 diabetic patients. Metabolism 50: 1136-1140, 2001.
52. Kanabrocki EL, Hermida RC, Wright M, Young RM, Bremner FW, Third JL, Ryan MD, Ayala DE, Johnson M, Nemchausky BA, Shirazi P, Scheving LE, and Olwin JH. Circadian variation of serum leptin in healthy and diabetic men. Chronobiol Int 18: 273-283, 2001.
53. Kanaley JA, Fenicchia LM, Miller CS, Ploutz-Synder LL, Weinstock RS, Carhart R, and Azevedo JL Jr. Resting leptin responses to acute and chronic resistance training in Type 2 diabetic men and women. Int J Obes Relat Metab Disord 25: 1474-1480, 2001.
54. Keller C, Keller P, Giralt M, Hidalgo J, and Pedersen BK. Exercise normalises overexpression of TNF-alpha in knockout mice. Biochem Biophys Res Commun 321: 179-182, 2004.
55. Keller C, Keller P, Marshal S, and Pedersen BK. IL-6 gene expression in human adipose tissue in response to exercise -effect of carbohydrate ingestion. J Physiol 550: 927-931, 2003.
56. Kern PA, Di Gregorio GB, Lu T, Rassouli N, and Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 52: 1779-1785, 2003.
57. Kern PA, Ranganathan S, Li C, Wood L, and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280: E745-E751, 2001.
58. Kim HJ, Higashimori T, Park SY, Choi H, Dong J, Kim YJ, Noh HL, Cho YR, Cline G, Kim YB, and Kim JK. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53: 1060-1067, 2004.
59. Klein S, Coppack SW, Mohamed-Ali V, and Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45: 984-987, 1996.
60. Kohrt WM, Landt M, and Birge SJ Jr. Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy, in older women. J Clin Endocrinol Metab 81: 3980-3985, 1996.
61. Koistinen HA, Tuominen JA, Ebeling P, Heiman ML, Stephens TW, and Koivisto VA. The effect of exercise on leptin concentration in healthy men and in Type 1 diabetic patients. Med Sci Sports Exerc 30: 805-810, 1998.
62. Kraemer RR, Aboudehen KS, Carruth AK, Durand RT, Acevedo EO, Hebert EP, Johnson LG, and Castracane VD. Adiponectin responses to continuous and progressively intense intermittent exercise. Med Sci Sports Exerc 35: 1320-1325, 2003.
63. Kraemer RR, Johnson LG, Haltom R, Kraemer GR, Hebert EP, Gimpel T, and Castracane VD. Serum leptin concentrations in response to acute exercise in postmenopausal women with and without hormone replacement therapy. Proc Soc Exp Biol Med 221: 171-177, 1999.
64. Landt M, Lawson GM, Helgeson JM, Davila-Roman VG, Ladenson JH, Jaffe AS, and Hickner RC. Prolonged exercise decreases serum leptin concentrations. Metabolism 46: 1109-1112, 1997.
65. Leal-Cerro A, Garcia-Luna PP, Astorga R, Parejo J, Peino R, Dieguez C, and Casanueva FF. Serum leptin levels in male marathon athletes before and after the marathon run. J Clin Endocrinol Metab 83: 2376-2379, 1998.
66. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, and Mantzoros CS. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88: 4848-4856, 2003.
67. Lepercq J, Cauzac M, Lahlou N, Timsit J, Girard J, Auwerx J, and Hauguel-de Mouzon S. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes 47: 847-850, 1998.
68. Lyngso D, Simonsen L, and Bulow J. Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise. J Physiol 543: 373-378, 2002.
69. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, and Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221: 286-289, 1996.
70. McTernan PG, Fisher FM, Valsamakis G, Chetty R, Harte A, McTernan CL, Clark PMS, Smith SA, Barnett AH, and Kumar S. Resistin and Type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 88: 6098-6106, 2003.
71. Mendoza-Nunez VM, Garcia-Sanchez A, Sanchez-Rodriguez M, Galvan-Duarte RE, and Fonseca-Yerena ME. Overweight, waist circumference, age, gender, and insulin resistance as risk factors for hyperleptinemia. Obes Res 10: 253-259, 2002.
72. Minokoshi Y and Kahn BB. Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. Biochem Soc Trans 31: 196-201, 2003.
73. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, and Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343, 2002.
74. Moller DE. Potential role of TNF-α in the pathogenesis of insulin resistance and Type 2 diabetes. Trends Endocrinol Metab 11: 212-217, 2000.
75. Moller DE and Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med, 2004.
76. Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, and Mantzoros CS. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 11: 1048-1054, 2003.
77. Nindl BC, Kraemer WJ, Arciero PJ, Samatallee N, Leone CD, Mayo MF, and Hafeman DL. Leptin concentrations experience a delayed reduction after resistance exercise in men. Med Sci Sports Exerc 34: 608-613, 2002.
78. Nolte LA, Hansen PA, Chen MM, Schluter JM, Gulve EA, and Holloszy JO. Short-term exposure to tumor necrosis factor-alpha does not affect insulin-stimulated glucose uptake in skeletal muscle. Diabetes 47: 721-726, 1998.
79. Ofei F, Hurel S, Newkirk J, Sopwith M, and Taylor R. Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45: 881-885, 1996.
80. Okazaki T, Himeno E, Nanri H, Ogata H, and Ikeda M. Effects of mild aerobic exercise and a mild hypocaloric diet on plasma leptin in sedentary women. Clin Exp Pharmacol Physiol 26: 415-420, 1999.
81. Olive JL and Miller GD. Differential effects of maximal- and moderate-intensity runs on plasma leptin in healthy trained subjects. Nutrition 17: 365-369, 2001.
82. Ostrowski K, Hermann C, Bangash A, Schjerling P, Nielsen JN, and Pedersen BK. A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol 513: 889-894, 1998.
83. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, and Scherer PE. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 278: 9073-9085, 2003.
84. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, and Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279: 12152-12162, 2004.
85. Parhami F, Tintut Y, Ballard A, Fogelman AM, and Demer LL. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 88: 954-960, 2001.
86. Pasman WJ, Westerterp-Plantenga MS, and Saris WH. The effect of exercise training on leptin levels in obese males. Am J Physiol Endocrinol Metab 274: E280-E286, 1998.
87. Perusse L, Collier G, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Nadeau A, Zimmet PZ, and Bouchard C. Acute and chronic effects of exercise on leptin levels in humans. J Appl Physiol 83: 5-10, 1997.
88. Privette JD, Hickner RC, Macdonald KG, Pories WJ, and Barakat HA. Fatty acid oxidation by skeletal muscle homogenates from morbidly obese black and white American women. Metabolism 52: 735-738, 2003.
89. Racette SB, Coppack SW, Landt M, and Klein S. Leptin production during moderate-intensity aerobic exercise. J Clin Endocrinol Metab 82: 2275-2277, 1997.
90. Reseland JE, Anderssen SA, Solvoll K, Hjermann I, Urdal P, Holme I, and Drevon CA. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr 73: 240-245, 2001.
91. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, and Drevon CA. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16: 1426-1433, 2001.
92. Ryan AS, Nicklas BJ, Berman DM, and Elahi D. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord 27: 1066-1071, 2003.
93. Saad MF, Riad-Gabriel MG, Khan A, Sharma A, Michael R, Jinagouda SD, Boyadjian R, and Steil GM. Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity. J Clin Endocrinol Metab 83: 453-459, 1998.
94. Saghizadeh M, Ong JM, Garvey WT, Henry RR, and Kern PA. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest 97: 1111-1116, 1996.
95. Schoeller DA, Cella LK, Sinha MK, and Caro JF. Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest 100: 1882-1887, 1997.
96. Sliwowski Z, Lorens K, Konturek SJ, Bielanski W, and Zoladz JA. Leptin, gastrointestinal and stress hormones in response to exercise in fasted or fed subjects and before or after blood donation. J Physiol Pharmacol 52: 53-70, 2001.
97. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, and Pfeiffer AF. Adiponectin and protection against Type 2 diabetes mellitus. Lancet 361: 226-228, 2003.
98. Steensberg A, Fischer CP, Sacchetti M, Keller C, Osada T, Schjerling P, van Hall G, Febbraio MA, and Pedersen BK. Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. J Physiol 548: 631-638, 2003.
99. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, and Tataranni PA. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51: 1884-1888, 2002.
100. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, and Lazar MA. The hormone resistin links obesity to diabetes. Nature 409: 307-312, 2001.
101. Thong FS, Hudson R, Ross R, Janssen I, and Graham TE. Plasma leptin in moderately obese men: independent effects of weight loss and aerobic exercise. Am J Physiol Endocrinol Metab 279: E307-E313, 2000.
102. Torjman MC, Zafeiridis A, Paolone AM, Wilkerson C, and Considine RV. Serum leptin during recovery following maximal incremental and prolonged exercise. Int J Sports Med 20: 444-450, 1999.
103. Trujillo ME and Scherer PE. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257: 167-175, 2005.
104. Ullum H, Haahr PM, Diamant M, Palmo J, Halkjaer-Kristensen J, and Pedersen BK. Bicycle exercise enhances plasma IL-6 but does not change IL-1α, IL-1β, IL-6, or TNF-α pre-mRNA in BMNC. J Appl Physiol 77: 93-97, 1994.
105. Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA, and Pedersen BK. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88: 3005-3010, 2003.
106. Vionnet N, Hani El H, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, and Froguel P. Genomewide search for Type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a Type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67: 1470-1480, 2000.
107. Vozarova de Courten B, Degawa-Yamauchi M, Considine RV, and Tataranni PA. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 53: 1279-1284, 2004.
108. Wagner R, Oberste-Bergbaus C, Herpertz S, Blum WF, Pelz B, Hebebrand J, Senf W, Mann K, and Albers N. Time relationship between circadian variation of serum levels of leptin, insulin and cortisol in healthy subjects. Horm Res 54: 174-180, 2000.
109. Wang J, Liu R, Hawkins M, Barzilai N, and Rossetti L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393: 684-688, 1998.
110. Weltman A, Pritzlaff CJ, Wideman L, Considine RV, Fryburg DA, Gutgesell ME, Hartman ML, and Veldhuis JD. Intensity of acute exercise does not affect serum leptin concentrations in young men. Med Sci Sports Exerc 32: 1556-1561, 2000.
111. Wiesner G, Vaz M, Collier G, Seals D, Kaye D, Jennings G, Lambert G, Wilkinson D, and Esler M. Leptin is released from the human brain: influence of adiposity and gender. J Clin Endocrinol Metab 84: 2270-2274, 1999.
112. Xu H, Uysal KT, Becherer JD, Arner P, and Hotamisligil GS. Altered tumor necrosis factor-α (TNF-α) processing in adipocytes and increased expression of transmembrane TNF-α in obesity. Diabetes 51: 1876-1883, 2002.
113. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, and Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295, 2002.
114. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, and Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946, 2001.
115. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, and Chuang LM. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86: 3815-3819, 2001.
116. Yatagai T, Nishida Y, Nagasaka S, Nakamura T, Tokuyama K, Shindo M, Tanaka H, and Ishibashi S. Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. Endocr J 50: 233-238, 2003.
117. Yokoyama H, Emoto M, Araki T, Fujiwara S, Motoyama K, Morioka T, Koyama H, Shoji T, Okuno Y, and Nishizawa Y. Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in Type 2 diabetes. Diabetes Care 27: 1756-1758, 2004.
118. Zaccaria M, Ermolao A, Roi GS, Englaro P, Tegon G, and Varnier M. Leptin reduction after endurance races differing in duration and energy expenditure. Eur J Appl Physiol 87: 108-111, 2002.
119. Zacharova J, Chiasson JL, and Laakso M. The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to Type 2 diabetes: the STOP-NIDDM trial. Diabetes 54: 893-899, 2005.
120. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, and Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994.